Opportunity
Specialized Clinical Laboratory Testing Services
Response due
September 17, 2026
- Agency
- National Institutes of Health Olao
- Estimated value
- Not stated
Notice of Intent: Specialized Clinical Laboratory Testing Services. (75N98026Q01207) The National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Mayo Collaborative Services Inc. under the authority of FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. The National Institutes of Health (NIH), intends to solicit and negotiate on a sole-source basis with Mayo Collaborative Services Inc. for the acquisition of Specialized Clinical Laboratory Testing Services. Mayo Collaborative Services, Inc. is the only source that can provide the required combination of specialized testing capabilities, established diagnostic methodologies, expert clinical interpretation, consultation, and coordinated follow-up testing as an integrated service. No alternative commercially available system provides the specific combination of capabilities. This notice is not a request for competitive quotations. However, any responsible source, including small business concerns (e.g., 8(a), HUBZone, Service-Disabled Veteran-Owned Small Business, Veteran-Owned Small Business, Women-Owned Small Business, and Small Disadvantaged Business), that believes it can satisfy the Government's requirement may submit a capability statement demonstrating its ability to provide a product that meets the Government's minimum technical requirements. Capability statements must include sufficient documentation to establish the ability to furnish an equivalent system. A determination by the Government not to compete this proposed acquisition based upon responses to this notice is solely within the discretion of the Government. Responses must be submitted via email to vensonm@mail.nih.gov no later than 9:00 a.m. EDT on September 17, 2026. It is anticipated that an award will be issued approximately five (5) days after the closing date of this notice, provided no acceptable capability statements are received.
Key dates
- Posted
- September 12, 2026
- Response due
- September 17, 2026
Who is this buyer
Organization
Buying history
- Records263 total
- Opportunities / awards10 / 20
- Value range$0 – $30,482,226
- ActiveJuly 15, 2026 – October 26, 2026
What they buy
- Clinical (251)
- Administrative (12)
Set-asides used
- No Set aside used (68)
- Small Business Set Aside - Total (14)
Who holds their work today
- EAGLE HEALTH, LLC1 win · $30,482,226 · last February 1, 2020
- LC INDUSTRIES INC1 win · $286,880 · last February 13, 2026
Also open from this buyer
- Clinical Research Support and Collaboration for NHGRI ProtocolsDue November 13, 2026 · Clinical
- NOI - 4D-Nucleofector Core Unit and X UnitDue November 5, 2026 · Clinical
- Reagents and consumables for Roche immunostainersDue October 28, 2026 · Clinical
- Combines Synopsis Solicitation- Automated SpatialDue November 5, 2026 · Clinical
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- No Set aside used
- NAICS
- 541380
- PSC
- Q301